<DOC>
	<DOCNO>NCT00893256</DOCNO>
	<brief_summary>Negative symptom schizophrenia present challenge clinician owe poorer response conventional treatment antipsychotic . Negative symptom schizophrenia may secondary psychotic symptom , depressive symptom , drug-related side effect lack environmental stimulation . Alternately , may represent core feature illness , characterize primary deficit symptom . Previous study suggest atypical antipsychotic may beneficial improve deficit symptom schizophrenia . This study aim characterizing nature improvement negative symptom early phase ( 12 week ) treatment atypical antipsychotic , risperidone . In order account factor contribute improvement secondary negative symptom , rating carry change positive symptom , depressive symptom drug-related side effect . Further , add-on citalopram placebo administer double-blind design study effect selective serotonin reuptake inhibitor ( SSRI ) augmentation risperidone negative symptom . The investigator hypothesize improvement negative symptom initial phase ( 12 week ) treatment risperidone largely account improvement secondary negative symptom , rather primary deficit symptom .</brief_summary>
	<brief_title>Effect Add-on Citalopram Risperidone Negative Symptoms Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Patients fulfil DSMIV Criteria Schizophrenia The patient drug na√Øve drug free one month ( oral antipsychotic ) three month parental antipsychotic Duration onset &lt; 5 year Informed consent Patient current Axis I Axis II comorbid disorder Comorbid substance abuse dependence except nicotine caffeine Presence significant medical disorder epilepsy , uncontrolled hypertension diabetes mellitus , thyroid disorder Patient respond adequate course risperidone ( reference dose duration ) Treatmentresistant schizophrenia define nonresponse three different antipsychotic belong least two different class , one atypical agent one depot neuroleptic Patient receive ECT past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>risperidone</keyword>
	<keyword>citalopram</keyword>
	<keyword>secondary negative symptom</keyword>
</DOC>